NM_024675.4:c.1563C>G
Variant summary
Our verdict is Benign. The variant received -11 ACMG points: 2P and 13B. PM2BP4_StrongBP6_Very_StrongBP7
The NM_024675.4(PALB2):c.1563C>G(p.Thr521Thr) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000657 in 152,152 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Synonymous variant affecting the same amino acid position (i.e. T521T) has been classified as Likely benign.
Frequency
Consequence
NM_024675.4 synonymous
Scores
Clinical Significance
Conservation
Publications
- hereditary breast carcinomaInheritance: AD Classification: DEFINITIVE Submitted by: ClinGen, Ambry Genetics
 - Fanconi anemia complementation group NInheritance: AR Classification: DEFINITIVE, STRONG Submitted by: G2P, Labcorp Genetics (formerly Invitae), ClinGen, Ambry Genetics
 - pancreatic cancer, susceptibility to, 3Inheritance: AD Classification: STRONG Submitted by: Genomics England PanelApp, Labcorp Genetics (formerly Invitae)
 - familial ovarian cancerInheritance: AD Classification: MODERATE Submitted by: ClinGen
 - Fanconi anemiaInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
 - hereditary nonpolyposis colon cancerInheritance: AD Classification: LIMITED Submitted by: ClinGen
 
Genome browser will be placed here
ACMG classification
Our verdict: Benign. The variant received -11 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes   AF:  0.00000657  AC: 1AN: 152152Hom.:  0  Cov.: 32 show subpopulations 
GnomAD4 exome Cov.: 33 
GnomAD4 genome   AF:  0.00000657  AC: 1AN: 152152Hom.:  0  Cov.: 32 AF XY:  0.0000135  AC XY: 1AN XY: 74330 show subpopulations  ⚠️ The allele balance in gnomAD version 4 Genomes is significantly skewed from the expected value of 0.5. 
ClinVar
Submissions by phenotype
Hereditary cancer-predisposing syndrome    Benign:2 
This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -
- -
Familial cancer of breast    Benign:2 
- -
This variant is considered benign. This variant is a silent/synonymous amino acid change and it is not expected to impact splicing. -
Computational scores
Source: 
Splicing
 Find out detailed SpliceAI scores and Pangolin per-transcript scores at